medigraphic.com
ISSN 2221-2434 (Electronic)

2022, Number 2

<< Back Next >>

Finlay 2022; 12 (2)

Subcutaneous post-mastectomy breast reconstruction with wise marking pattern. A case report

Rojas BR, Hechavarría JY, Pérez PA, Lores CA

Language: Spanish
References: 12
Page: 232-238
PDF size: 214.50 Kb.


ABSTRACT

Risk-reducing mastectomy, also known as prophylactic mastectomy, involves removing as much tissue as possible from a healthy breast to reduce the potential risk of developing cancer. A case of a 30-years-old, black-skinned, multiparous patient with a history of suffering from a very young macrocystic breast disease is presented. This patient had undergone bilateral subcutaneous mastectomy 10 years ago due to macrocystic disease and had no possibility of implants on that occasion, which caused unaesthetic scars and psychological sequelae. The patient went to the Plastic Surgery Service of the Botswana Prince Marina Hospital in Africa requesting aesthetic correction. With the intervention, a harmonic breast was achieved, although small, with autologous tissues, without major complications and with the prospect of future breast volume increase with autologous tissues. In this patient, aesthetic reconstruction was a necessary and effective option given her socioeconomic context. The case is presented due to the interesting nature of this type of intervention carried out by Cuban specialists in their medical collaboration in an African country.


REFERENCES

  1. Peiris L, Olson D, Kelly D. Oncoplastic and reconstructive breast surgery in Canada: breaking new ground in general surgical training. Can J Sur. 2018;61(5):294-9.

  2. Kronowitz SJ. State of the art and science in postmastectomy breast reconstruction. Plast Reconstr Surg. 2015;135(4):755e-71e.

  3. Kim MK, Kim T, Moon HG, Jin US, Kim K, Kim J, et al. Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol. 2015;41(3):426-32.

  4. Sánchez L, Alfonso L, Sánchez IG, Ramos M, Ropero RJ. Reconstrucción mamaria inmediata en el Instituto Nacional de Oncología y Radiobiología de Cuba. Rev Cubana Cir[Internet]. 2020[citado 2 Ene 2022];59(4):[aprox. 10p.]. Disponible en: https://www.revcirugia.sld.cu/index.php/cir/article/view/10304.

  5. Avellaneda EM, García A, Palacios P, Pacheco FJ, Acea B, Albaina L. Mastectomía ahorradora de piel tipo IV con injerto libre de areola-pezón para reconstrucción con prótesis en cirugía reductora de riesgo. Cir Plást Iberolatinoam[Internet]. 2019[citado 2 Ene 2020];45(2):[aprox. 12p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-789220190002000065.

  6. Gutiérrez C, Rivas B, Cárdenas A. Secuelas de mastectomía subcutánea profiláctica: caso clínico. Cirug Plást Iberolatinoam[Internet]. 2008[citado 19 May 2022];34(4):[aprox. 5p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-789220080004000076.

  7. Marré D, Gantz JT, Villalón J, Roco H. Reconstrucción Mamaria: Estado Actual Del Tema. Rev Chil Cir[Internet]. 2016[citado 28 Abr 2022];68(2):[aprox. 7p.]. Disponible en: https://dx.doi.org/10.4067/S0718-402620160002000147.

  8. Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, et al. Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis. Ann Surg. 2016;263(2):219-27.

  9. Ricaño RR, Vázquez LG. Reconstrucción postmastectomía con técnica de Bostwick e injerto de areola pezón en mamas hipertróficas y ptósicas. Cir Plást[Internet]. 2017[citado 2 Ene 2020];27(3):[aprox. 6p.]. Disponible en: https://www.medigraphic.com/cirugiaplastica9.

  10. Arellano R, Ramírez LR, Saucedo JA, González A, Fuentes C , Pérez JE. Reconstrucción mamaria postmastectomía. Análisis y resultados en un hospital de tercer nivel en México. Cir Plást Iberolatinoam[Internet]. 2018[citado 2 Ene 2020];44(2):[aprox. 12p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-7892201800020001110.

  11. Cervilla JM. Ventajas del implante graso autólogo sobre el implante aloplástico en la mama tuberosa. Cir Plást Iberolatinoam[Internet]. 2020[citado 20 Dic 2021];46(3):[aprox. 14p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-7892202000040000311.

  12. Jung HK, Kim CH, Song SY. Prospective 1-year follow-up study of breast augmentation by cell-assisted lipotransfer. Aesthet Surg J. 2016;36(2):179-90.




2020     |     www.medigraphic.com